CL2018002006A1 - Anti-cd3 antibodies and methods of use (divisional application 201601556) - Google Patents

Anti-cd3 antibodies and methods of use (divisional application 201601556)

Info

Publication number
CL2018002006A1
CL2018002006A1 CL2018002006A CL2018002006A CL2018002006A1 CL 2018002006 A1 CL2018002006 A1 CL 2018002006A1 CL 2018002006 A CL2018002006 A CL 2018002006A CL 2018002006 A CL2018002006 A CL 2018002006A CL 2018002006 A1 CL2018002006 A1 CL 2018002006A1
Authority
CL
Chile
Prior art keywords
antibodies
methods
divisional application
clusters
divisional
Prior art date
Application number
CL2018002006A
Other languages
Spanish (es)
Inventor
Robert F Kelly
Xiaocheng Chen
Mark S Dennis
Mary A Mathieu
Liping L Sun
Allen J Ebens Jr
Teemu T Junttilla
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CL2018002006A1 publication Critical patent/CL2018002006A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

LA INVENCIÓN PROPORCIONA LOS ANTICUERPOS 3 (CD3) DE LOS ANTI-CÚMULOS DE DIFERENCIACIÓN Y LOS MÉTODOS PARA UTILIZARLOS.THE INVENTION PROVIDES THE ANTIBODIES 3 (CD3) OF THE DIFFERENTIATION ANTI-CLUSTERS AND THE METHODS TO USE THEM.

CL2018002006A 2013-12-17 2018-07-24 Anti-cd3 antibodies and methods of use (divisional application 201601556) CL2018002006A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361917346P 2013-12-17 2013-12-17
US201461949950P 2014-03-07 2014-03-07
US201462026594P 2014-07-18 2014-07-18
US201462091441P 2014-12-12 2014-12-12
US201862053582P 2018-09-22 2018-09-22

Publications (1)

Publication Number Publication Date
CL2018002006A1 true CL2018002006A1 (en) 2018-08-31

Family

ID=65529109

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002006A CL2018002006A1 (en) 2013-12-17 2018-07-24 Anti-cd3 antibodies and methods of use (divisional application 201601556)

Country Status (1)

Country Link
CL (1) CL2018002006A1 (en)

Similar Documents

Publication Publication Date Title
CR20160314A (en) ANTI-CD3 ANTIBODIES AND METHODS OF USE
CL2016001432A1 (en) New anti-dpep3 antibodies and methods of use
CL2016002816A1 (en) Anti-cd 134 antibodies (ox40) and uses thereof (divisional sol. No. 631-14).
CL2019000334A1 (en) New antibody conjugates and uses thereof (divisional application 201502357)
CL2018000595A1 (en) Anti-PD1 antibodies and methods of use
CL2018000829A1 (en) Human anti-cd19 antibodies with high affinity
CL2015002562A1 (en) Anti-b7-h4 antibodies and immunoconjugates
CL2018000479A1 (en) Lymphoopeitin strimal tomica (tslp) - binding antibodies and methods of antibody use
CL2017000545A1 (en) Anti-her2 and immunoconjugate antibodies
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
CR20180013A (en) ANTI-TAU ANTIBODIES AND METHODS OF USE.
CR20140212A (en) ANTI-HTRA1 ANTIBODIES AND METHODS OF USE
CR20150618A (en) ANTITRANSPHERINE RECEIVING ANTIBODIES AND METHODS OF USE
CR20140382A (en) ANTI-LRP5 ANTIBODIES AND METHODS OF USE
CO6721041A2 (en) Anti-pcsk9 antibody and methods of use
CR20170230A (en) ANTI-CD79B ANTIBODIES AND METHODS OF USE
UY34815A (en) BISPECIFIC ANTIBODIES AND THEIR METHODS OF USE
CR20160270A (en) ANTI-TAU ANTIBODIES (pS422) HUMANIZED AND USED METHODS
CR20160362A (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF USE
BR112015021521A2 (en) anti-crth2 antibodies and methods for their use
EA201590993A1 (en) HETERODIMERNY IMMUNOHLOBULINS
CR20150247A (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
MX2015013901A (en) Anti-il-4 antibodies and bispecific antibodies and uses thereof.
CL2015002724A1 (en) Methods to treat crohn's disease using an anti-il23 antibody
CR20150585A (en) ANTI-IGF-1R ANTIBODIES WITH ABOLITION OF THE UNION TO THE FCRN AND ITS USE IN THE TREATMENT OF VASCULAR EYE DISEASES